CYTOKINETICS INC — Director's Dealing 2022

Sep 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2022-09-01

Reporting Person: WIERENGA WENDALL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-01	Common Stock	M	4166	$6.78	Acquired	16336	Direct
2022-09-01	Common Stock	S	4166	$52.79	Disposed	12170	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-01	Non-Qualified Stock Option (Right to Buy)	$6.78	M	4166	Disposed	2023-05-22	Common Stock (4166)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022.